Pediatric cancer recurrence prediction has taken a significant leap forward with the integration of artificial intelligence in medicine.A groundbreaking study reveals that an innovative AI tool can evaluate multiple MRI scans over time, offering a more accurate assessment of cancer relapse risk in young patients than conventional methods.